Moberg Pharma AB (MBGPF)
1.10
0.00 (0.00%)
USD |
OTCM |
Aug 26, 16:00
Moberg Pharma EPS Diluted (Quarterly) : -0.0075 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0075 |
| March 31, 2026 | -0.003 |
| December 31, 2025 | -0.0288 |
| September 30, 2025 | -0.0097 |
| June 30, 2025 | -0.0164 |
| March 31, 2025 | -0.0056 |
| December 31, 2024 | -0.4834 |
| September 30, 2024 | -0.0026 |
| June 30, 2024 | -0.0126 |
| March 31, 2024 | -0.0224 |
| December 31, 2023 | -0.0216 |
| September 30, 2023 | -0.0336 |
| June 30, 2023 | -0.0248 |
| March 31, 2023 | -0.0327 |
| December 31, 2022 | -0.0197 |
| September 30, 2022 | -0.0273 |
| June 30, 2022 | -0.0416 |
| March 31, 2022 | -0.0695 |
| December 31, 2021 | -0.0666 |
| September 30, 2021 | -0.0661 |
| June 30, 2021 | -0.0577 |
| March 31, 2021 | 0.3592 |
| December 31, 2020 | -0.2541 |
| September 30, 2020 | -0.1597 |
| June 30, 2020 | -0.1649 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.1072 |
| June 30, 2019 | -0.3409 |
| March 31, 2019 | 0.2903 |
| December 31, 2018 | 0.393 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.1764 |
| March 31, 2018 | 0.0807 |
| December 31, 2017 | 0.3764 |
| September 30, 2017 | 0.4961 |
| June 30, 2017 | -0.291 |
| March 31, 2017 | -0.1085 |
| December 31, 2016 | -0.107 |
| September 30, 2016 | 0.5946 |
| June 30, 2016 | 1.358 |
| March 31, 2016 | -0.2692 |
| December 31, 2015 | 0.0201 |
| September 30, 2015 | 0.4093 |
| June 30, 2015 | 0.2569 |
| March 31, 2015 | 0.5118 |
| December 31, 2014 | -0.0153 |
| September 30, 2014 | 0.2542 |
| June 30, 2014 | 0.2846 |
| March 31, 2014 | 0.2995 |
| December 31, 2013 | -0.035 |
| September 30, 2013 | -0.2954 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Orexo AB | -0.3052 |
| Swedencare AB | 0.0158 |
| Camurus AB | 0.432 |
| Infant Bacterial Therapeutics AB | -0.1863 |
| AstraZeneca PLC | 0.9849 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.3504M |
| Revenue (Quarterly) | 0.6157M |
| Total Expenses (Quarterly) | 0.9661M |
| Enterprise Value | 30.13M |
| Gross Profit Margin (Quarterly) | 65.36% |
| Profit Margin (Quarterly) | -56.91% |
| Earnings Yield | -4.45% |
| Normalized Earnings Yield | -4.446 |